Article

BioPharm International Multimedia

Cell Therapies

Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about emerging trends in cell therapy.

Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about emerging trends in cell therapy. 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Ribosome translating mRNA into a polypeptide chain | Image Credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com
September 4th 2025

Quotient Sciences and CPI Target Faster RNA-Based Drug Development

Feliza Mirasol
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
September 4th 2025

What the Aptamer-Invizius H-Guard Immune Modulation Collab Means for Biopharma

Feliza Mirasol
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 4th 2025

MS Pharma and Polpharma Biologics Partner to Expand Biosimilar Access in MENA

Feliza Mirasol
medical ampoules packaging | Image Credit: © macondos - © macondos - stock.adobe.com
September 4th 2025

SGD Pharma to Acquire Alphial Tubular Glass Manufacturer

Feliza Mirasol
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
September 4th 2025

Lineage, WDI Research Partnership Targets Cell Therapy for Hearing Loss

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
September 4th 2025

FDA Grants Breakthrough Therapy Designation to Bispecific ADC for EGFR-Mutant Lung Cancer

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.